BRPI0518809A2 - modulaÇço da ovulaÇço - Google Patents

modulaÇço da ovulaÇço

Info

Publication number
BRPI0518809A2
BRPI0518809A2 BRPI0518809-1A BRPI0518809A BRPI0518809A2 BR PI0518809 A2 BRPI0518809 A2 BR PI0518809A2 BR PI0518809 A BRPI0518809 A BR PI0518809A BR PI0518809 A2 BRPI0518809 A2 BR PI0518809A2
Authority
BR
Brazil
Prior art keywords
ovulation
modulation
gdf
molecules
domain
Prior art date
Application number
BRPI0518809-1A
Other languages
English (en)
Inventor
Jennifer Lee Juengel
Kenneth Pattrick Mcnatty
Loyd Gary Moore
Robert Syndecombe Bower
Original Assignee
Agres Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from NZ53694304A external-priority patent/NZ536943A/en
Application filed by Agres Ltd filed Critical Agres Ltd
Publication of BRPI0518809A2 publication Critical patent/BRPI0518809A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Reproductive Health (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

MODULAÇçO DA OVULAÇçO. A presente invenção é dirigida à identificação de um domínio inédito de importância funcional nas moléculas de GDF-9 e GDF-9B e aos peptídeos e anticorpos que interagem com o domínio para modular a atividade biológica dessas moléculas a fim de alterar a função ovariana a taxa de ovulação de mamíferos.
BRPI0518809-1A 2004-12-02 2005-12-02 modulaÇço da ovulaÇço BRPI0518809A2 (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
NZ53694304A NZ536943A (en) 2004-12-02 2004-12-02 Modulation of ovulation
NZ53903905 2005-03-24
NZ54117005 2005-07-08
PCT/NZ2005/000313 WO2006059913A1 (en) 2004-12-02 2005-12-02 Modulation of ovulation

Publications (1)

Publication Number Publication Date
BRPI0518809A2 true BRPI0518809A2 (pt) 2008-12-09

Family

ID=36565307

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0518809-1A BRPI0518809A2 (pt) 2004-12-02 2005-12-02 modulaÇço da ovulaÇço

Country Status (6)

Country Link
EP (1) EP1819722A4 (pt)
JP (1) JP2008521891A (pt)
AU (1) AU2005310356A1 (pt)
BR (1) BRPI0518809A2 (pt)
CA (1) CA2589898A1 (pt)
WO (1) WO2006059913A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006130022A1 (en) * 2005-05-30 2006-12-07 Agresearch Limited Modulation of ovulation by agonists and antagonists of bmprii
US8530235B2 (en) 2005-07-18 2013-09-10 Adelaide Research & Innovation Pty Ltd. Medium that supports culture of an oocyte and modulation of granulosa cell apoptosis
BRPI0706173C1 (pt) * 2007-11-23 2011-02-22 Brasil Pesquisa Agropec metodo para identificação massal de animais com aumento na prolificidade
WO2019213690A1 (en) 2018-05-09 2019-11-14 Monash University Agentand method forenhancing fertility

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5821056A (en) * 1993-01-12 1998-10-13 The Johns Hopkins University School Of Medicine Growth differentiation factor-9
US6030617A (en) * 1993-01-12 2000-02-29 The Johns Hopkins University School Of Medicine Use of growth differentiation factor-9 (GDF-9) to inhibit oocyte maturation
NZ519330A (en) * 2002-05-30 2004-12-24 George Henry Davis New sequences for altering mammalian ovarian function and ovulation rate

Also Published As

Publication number Publication date
EP1819722A1 (en) 2007-08-22
JP2008521891A (ja) 2008-06-26
AU2005310356A1 (en) 2006-06-08
CA2589898A1 (en) 2006-06-08
WO2006059913A1 (en) 2006-06-08
EP1819722A4 (en) 2009-09-09
WO2006059913A9 (en) 2008-05-22

Similar Documents

Publication Publication Date Title
BRPI0611800A2 (pt) formulaÇço estÁvel de anticorpo
BR112022017986A2 (pt) Anticorpos anticoronavírus e métodos de uso
GT200900264A (es) Moléculas y métodos para modular la pro-proteina
BR112014030098A2 (pt) métodos de rotulagem específica de sítio e moléculas produzidas pelos mesmos
BRPI0719953B8 (pt) anticorpos humanos de alta afinidade para receptor de il-4 humano
PA8850101A1 (es) Combinaciones antitumorales que contienen anticuerpos
EA200870571A1 (ru) Усовершенствования основ
DE602007011620D1 (de) Medizinisches abgabesystem mit asymmetrischen kodiervorrichtungen
BRPI0409872A (pt) válvula de medição
MX2012004619A (es) Ensayos regulados mediante proximidad para detectar proteinas de fusion oncogenicas.
BRPI0515940A (pt) membro linear
BR112015008376A2 (pt) conjugados fármaco-proteína
WO2008021484A3 (en) Assay system to identify therapeutic agents
ATE242650T1 (de) Gerät zur abgabe von flüssigkeiten
BRPI0508732A (pt) composição de um produto de beleza para limpeza
MX386714B (es) Anticuerpos de dominio simple dirigidos al grupo de diferenciación 1d (cd1d).
BR112022013878A2 (pt) Anticorpos que ligam integrina avb8 e utilizações dos mesmos
BRPI0518809A2 (pt) modulaÇço da ovulaÇço
BRPI0800377A (pt) bastão de tinta de travamento de múltiplas posições
BRPI0704529A2 (pt) mÉtodos e dispositivos para a iluminaÇço percutÂnea
BR112015026490A2 (pt) ensaio rápido ligado a enzima imunoenzimática para detecção e identificação de patógenos e determinação da susceptibilidade antimicrobiana
WO2005059517A3 (en) Toll-like receptor assays
BRPI0507019A (pt) composição, uso de anticorpo, anticorpo, uso de msrv/herv-w env-su
AR065336A1 (es) Preparacion de fluidos biologicos viralmente inactivados que tienen alta actividad de alfa -2- antiplasmina
MX2023001490A (es) Moleculas de union a il27r\03b1 y metodos de uso.

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired